Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 48, Issue 9

Issues

Transfer of myxovirus-protein-A mRNA assay for interferon-β bioactivity measurement in multiple sclerosis patients to routine laboratory practice. A 4-year experience

Cinzia Zanotti / Claudia Ghidini / Cinzia Lamorgese / Luigi Caimi / Ruggero Capra / Luisa Imberti
Published Online: 2010-08-03 | DOI: https://doi.org/10.1515/CCLM.2010.263

Abstract

Background: As new biomarkers are validated and their significance in the natural history of specific diseases is established, these technologies can be rapidly transferred to clinical application. Since it has been shown that a single post-interferon-β (IFNβ) injection measurement of myxovirus-protein-A (MxA) mRNA correlates with IFNβ bioactivity in IFNβ treated patients with multiple sclerosis (MS), we had previously validated an assay for its quantification.

Methods: We introduced a real-time PCR relative quantification assay into routine clinical practice and measured MxA mRNA expression in 564 samples from 500 unselected IFNβ treated MS patients over a 4-year period.

Results: We confirmed that the assay is reproducible over time, and found that the percentage of patients lacking MxA mRNA induction is comparable to that described in studies performed worldwide after patient selection by pre-screening for the presence of anti-IFNβ antibodies.

Conclusions: In view of its simplicity and reproducibility, this MxA assay is an alternative to anti-IFNβ antibody determinations for use in routine clinical practice.

Clin Chem Lab Med 2010;48:1235–8.

Keywords: interferon-β; multiple sclerosis; myxovirus-protein-A; routine laboratory practice

About the article

Corresponding author: Dr. Luisa Imberti, Laboratorio di Biotecnologie, Diagnostics Department, Spedali Civili di Brescia, Piazzale Spedali Civili, 1, 25123 Brescia, Italy Phone: +39-030-3995408, Fax: +39-030-3995095,


Received: 2010-01-04

Accepted: 2010-03-03

Published Online: 2010-08-03

Published in Print: 2010-09-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 48, Issue 9, Pages 1235–1238, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2010.263.

Export Citation

©2010 by Walter de Gruyter Berlin New York.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
M Chiarini, F Serana, C Zanotti, R Capra, S Rasia, M Rottoli, M Rovaris, D Caputo, G Cavaletti, M Frigo, B Frigeni, R Clerici, M Rezzonico, L Caimi, and L Imberti
Multiple Sclerosis Journal, 2012, Volume 18, Number 6, Page 788
[2]
Federico Serana, Luisa Imberti, Maria Pia Amato, Giancarlo Comi, Claudio Gasperini, Angelo Ghezzi, Vittorio Martinelli, Leandro Provinciali, Maria Rosa Rottoli, Stefano Sotgiu, Sergio Stecchi, Michele Vecchio, Mauro Zaffaroni, Cinzia Cordioli, Ruggero Capra, and Pablo Villoslada
PLoS ONE, 2014, Volume 9, Number 4, Page e94794
[3]
Elisabet Matas, Laura Bau, María Martínez-Iniesta, Lucía Romero-Pinel, M. Alba Mañé-Martínez, Álvaro Cobo-Calvo, and Sergio Martínez-Yélamos
Journal of Neuroimmunology, 2016, Volume 291, Page 73
[4]
A. Bertolotto, L. Granieri, F. Marnetto, P. Valentino, A. Sala, M. Capobianco, S. Malucchi, A. Di Sapio, M. Malentacchi, M. Matta, and M. Caldano
Cytokine & Growth Factor Reviews, 2015, Volume 26, Number 2, Page 241
[5]
Bulent Cakal, Ugur Uygunoglu, Sabahattin Saip, Ayse Altintas, Aksel Siva, and Selim Badur
Journal of Immunoassay and Immunochemistry, 2014, Volume 35, Number 4, Page 398
[6]
Antonio Bertolotto, Marco Capobianco, Maria Pia Amato, Elisabetta Capello, Ruggero Capra, Diego Centonze, Maria Di Ioia, Antonio Gallo, Luigi Grimaldi, Luisa Imberti, Alessandra Lugaresi, Chiara Mancinelli, Maria Giovanna Marrosu, Lucia Moiola, Enrico Montanari, Silvia Romano, Luigina Musu, Damiano Paolicelli, Francesco Patti, Carlo Pozzilli, Silvia Rossi, Marco Salvetti, Gioachino Tedeschi, Maria Rosaria Tola, Maria Troiano, Mauro Zaffaroni, and Simona Malucchi
Neurological Sciences, 2014, Volume 35, Number 2, Page 307
[7]
Sara Salehi Hammerstad, Frode Lars Jahnsen, Sisko Tauriainen, Heikki Hyöty, Trond Paulsen, Ingrid Norheim, and Knut Dahl-Jørgensen
Thyroid, 2014, Volume 24, Number 3, Page 537
[8]
Joep Killestein and Chris H. Polman
Nature Reviews Neurology, 2011, Volume 7, Number 4, Page 221
[9]
Stephen Krieger
Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011, Volume 78, Number 2, Page 192

Comments (0)

Please log in or register to comment.
Log in